The Global Digital Psychotherapeutics Market Size is valued at USD 1.27 billion in 2023 and is predicted to reach USD 8.47 billion by the year 2031 at a 26.90% CAGR during the forecast period for 2024-2031.
The use of digital technology, software apps, and digital platforms to deliver evidence-based therapy interventions for mental health issues is referred to as digital psychotherapeutics, also known as digital therapies for mental health or digital mental health interventions. The digital psychotherapeutics market has undergone substantial expansion and shifting dynamics in recent years.
The worldwide mental health crisis is becoming more widely recognized, with an increase in mental health illnesses such as depression, anxiety, and stress-related ailments. As a result, there is a rise in demand for accessible and effective psychotherapy interventions. Smartphones, wearables, and virtual reality (VR) are examples of how rapid advances in digital technology have paved the way for creative digital psychotherapy solutions. These technologies make therapy more convenient and scalable, making mental healthcare more accessible to a greater population.
However, the pandemic has increased the global demand for mental health care. The pandemic's dread, uncertainty, and social isolation have contributed to an increase in mental health illnesses, including anxiety, depression, and stress-related ailments.
The digital psychotherapeutics market is segmented by type, indication, business model, application, and end user. Based on type, the market is segmented into mobile apps, online platforms, virtual reality, wearable devices. the market is segmented by indication into phobias and anxiety disorders, psychotic disorders, other indications. the market is segmented by business model into direct-to-patients or consumers, business-to-business (b2b), by application the market is segmented into prevention, management, treatment. by end user the market is segmented into healthcare providers, payers.
The business-to-business (B2B) category is expected to hold a major share of the global Digital Psychotherapeutics Market. Owing to the increased awareness of the benefits and cost-effectiveness of digital medicines among providers, payers, and employers, the business-to-business (B2B) segment accounts for the largest market share. Furthermore, several pharmaceutical companies are focusing on developing digital treatments in conjunction with pharmacological goods in order to increase adherence and compliance.
The treatment segment is projected to grow at a rapid rate in the global digital psychotherapeutics market. Digital therapeutics are health or social care interventions delivered via a smart device to support healthy behaviors and provide therapeutic effects for treating type II diabetes, Alzheimer's disease, dementia, chronic obstructive pulmonary disease, asthma, and other disorders. Increase in research and development activity for digital therapeutic devices.
The North America Digital Psychotherapeutics Market is predicted to register the most increased market share in terms of revenue in the near future due to the increasing technological advancement for digital therapeutics advancements.
The movement in healthcare providers' focus towards a patient-centric healthcare approach for patient wellness. This region is home to a large number of enterprises that produce digital therapies. Because of increased investment and support for digital medicines development, the United States holds the largest market share. The evolving reimbursement system for digital treatments will drive industry expansion.
North America is also predicted to maintain its dominant market position over the forecasted timeframe. Because of increased research and development activity for digital therapies, the Asia Pacific region is likely to have significant market growth.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 1.27 Bn |
| Revenue Forecast in 2031 | USD 8.47 Bn |
| Growth rate CAGR | CAGR of 26.90 % from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments Covered | Type, By Indication, By Business Model, By Application, By End User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia; |
| Competitive Landscape | AbleTo Inc., BetterHelp Inc., Ginger.io Inc., Meru Health Inc., Novartis International AG, Pear Therapeutics Inc., SilverCloud Health Limited, Spring Health Inc., Starling Minds Inc., SwissDT AG, Talkspace Inc., Woebot Health Inc., CBT Nuggets LLC, Quartet Health Inc., Neurotrack Technologies Inc., Limbix Health Inc., Happify Health LLC, Mindstrong Health Inc., Minddistrict B.V., Ieso Digital Health, Eleos Health, MDLIVE, Lyra Health. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Digital Psychotherapeutics Market-
Digital Psychotherapeutics Market- By Type
Digital Psychotherapeutics Market- By Indication
Digital Psychotherapeutics Market- By Business Model
Digital Psychotherapeutics Market- By Application
Digital Psychotherapeutics Market- By End User
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Psychotherapeutic Market Snapshot
Chapter 4. Global Digital Psychotherapeutic Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Mobile Apps
5.2.2. Online Platforms
5.2.3. Virtual Reality
5.2.4. Wearable Devices
Chapter 6. Market Segmentation 2: by Indication Estimates & Trend Analysis
6.1. by Indication & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Indication:
6.2.1. Phobias And Anxiety Disorders
6.2.2. Psychotic Disorders
6.2.3. Other Indications
Chapter 7. Market Segmentation 3: by Business Model Estimates & Trend Analysis
7.1. by Business Model & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Business Model:
7.2.1. Direct-To-Patients or Consumers
7.2.2. Business-To-Business (B2B)
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
8.2.1. Prevention
8.2.2. Management
8.2.3. Treatment
Chapter 9. Market Segmentation 5: by End User Estimates & Trend Analysis
9.1. by End User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
9.2.1. Healthcare Providers
9.2.2. Payers
Chapter 10. Digital Psychotherapeutic Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.1.2. North America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
10.1.3. North America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Business Model, 2024-2031
10.1.4. North America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.1.5. North America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.1.6. North America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.2.2. Europe Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
10.2.3. Europe Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Business Model, 2024-2031
10.2.4. Europe Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.2.5. Europe Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.2.6. Europe Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.3.2. Asia Pacific Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
10.3.3. Asia-Pacific Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Business Model, 2024-2031
10.3.4. Asia-Pacific Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.3.5. Asia-Pacific Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.3.6. Asia Pacific Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.4. Latin America
10.4.1. Latin America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.4.2. Latin America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
10.4.3. Latin America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Business Model, 2024-2031
10.4.4. Latin America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.4.5. Latin America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.4.6. Latin America Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.5.2. Middle East & Africa Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
10.5.3. Middle East & Africa Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Business Model, 2024-2031
10.5.4. Middle East & Africa Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.5.5. Middle East & Africa Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.5.6. Middle East & Africa Digital Psychotherapeutic Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. AbleTo Inc.
11.2.2. BetterHelp Inc.
11.2.3. Ginger.io Inc.
11.2.4. Meru Health Inc.
11.2.5. Novartis International AG
11.2.6. Pear Therapeutics Inc.
11.2.7. SilverCloud Health Limited
11.2.8. Spring Health Inc.,
11.2.9. Starling Minds Inc.
11.2.10. SwissDT AG, Talkspace Inc.
11.2.11. Woebot Health Inc.
11.2.12. CBT Nuggets LLC
11.2.13. Quartet Health Inc.
11.2.14. Neurotrack Technologies Inc.
11.2.15. Limbix Health Inc.
11.2.16. Happify Health LLC
11.2.17. Mindstrong Health Inc.
11.2.18. Minddistrict B.V.
11.2.19. Ieso Digital Health
11.2.20. Eleos Health
11.2.21. MDLIVE
11.2.22. Lyra Health
11.2.23. Other Prominent Players